These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
327 related articles for article (PubMed ID: 24103642)
21. Rearrangement of the dendritic morphology in limbic regions and altered exploratory behavior in a rat model of autism spectrum disorder. Bringas ME; Carvajal-Flores FN; López-Ramírez TA; Atzori M; Flores G Neuroscience; 2013 Jun; 241():170-87. PubMed ID: 23535253 [TBL] [Abstract][Full Text] [Related]
22. Changes in chromatin structure in NIH 3T3 cells induced by valproic acid and trichostatin A. Felisbino MB; Gatti MS; Mello ML J Cell Biochem; 2014 Nov; 115(11):1937-47. PubMed ID: 24913611 [TBL] [Abstract][Full Text] [Related]
25. [Gender-dependent effects of histone deacetylase inhibitor sodium valproate on early olfactory learning in 129Sv mice]. Burenkova OV; Aleksandrova EA; Zaraĭskaia IIu Ross Fiziol Zh Im I M Sechenova; 2013 Feb; 99(2):212-20. PubMed ID: 23650734 [TBL] [Abstract][Full Text] [Related]
26. Exposure to valproic acid inhibits chondrogenesis and osteogenesis in mid-organogenesis mouse limbs. Paradis FH; Hales BF Toxicol Sci; 2013 Jan; 131(1):234-41. PubMed ID: 23042728 [TBL] [Abstract][Full Text] [Related]
27. Behavioral alterations in rats prenatally exposed to valproic acid: animal model of autism. Schneider T; Przewłocki R Neuropsychopharmacology; 2005 Jan; 30(1):80-9. PubMed ID: 15238991 [TBL] [Abstract][Full Text] [Related]
28. Sociability deficits after prenatal exposure to valproic acid are rescued by early social enrichment. Campolongo M; Kazlauskas N; Falasco G; Urrutia L; Salgueiro N; Höcht C; Depino AM Mol Autism; 2018; 9():36. PubMed ID: 29946415 [TBL] [Abstract][Full Text] [Related]
29. Anticancer agent ellipticine combined with histone deacetylase inhibitors, valproic acid and trichostatin A, is an effective DNA damage strategy in human neuroblastoma. Poljakova J; Hrebackova J; Dvorakova M; Moserova M; Eckschlager T; Hrabeta J; Göttlicherova M; Kopejtkova B; Frei E; Kizek R; Stiborova M Neuro Endocrinol Lett; 2011; 32 Suppl 1():101-16. PubMed ID: 22167207 [TBL] [Abstract][Full Text] [Related]
30. In utero exposure to valproic acid and autism--a current review of clinical and animal studies. Roullet FI; Lai JK; Foster JA Neurotoxicol Teratol; 2013; 36():47-56. PubMed ID: 23395807 [TBL] [Abstract][Full Text] [Related]
31. Competitive inhibition of histone deacetylase activity by trichostatin A and butyrate. Sekhavat A; Sun JM; Davie JR Biochem Cell Biol; 2007 Dec; 85(6):751-8. PubMed ID: 18059533 [TBL] [Abstract][Full Text] [Related]
32. Characterization of in utero valproic acid mouse model of autism by local field potential in the hippocampus and the olfactory bulb. Cheaha D; Bumrungsri S; Chatpun S; Kumarnsit E Neurosci Res; 2015 Sep; 98():28-34. PubMed ID: 25941101 [TBL] [Abstract][Full Text] [Related]
33. Acute prenatal exposure to a moderate dose of valproic acid increases social behavior and alters gene expression in rats. Cohen OS; Varlinskaya EI; Wilson CA; Glatt SJ; Mooney SM Int J Dev Neurosci; 2013 Dec; 31(8):740-50. PubMed ID: 24055786 [TBL] [Abstract][Full Text] [Related]
34. The mood stabilizer valproate activates human FGF1 gene promoter through inhibiting HDAC and GSK-3 activities. Kao CY; Hsu YC; Liu JW; Lee DC; Chung YF; Chiu IM J Neurochem; 2013 Jul; 126(1):4-18. PubMed ID: 23647222 [TBL] [Abstract][Full Text] [Related]
35. Human adipose-derived stem cells ameliorate repetitive behavior, social deficit and anxiety in a VPA-induced autism mouse model. Ha S; Park H; Mahmood U; Ra JC; Suh YH; Chang KA Behav Brain Res; 2017 Jan; 317():479-484. PubMed ID: 27717813 [TBL] [Abstract][Full Text] [Related]
36. Histone deacetylase inhibition results in decreased macrophage CD9 expression. Wang XQ; Alfaro ML; Evans GF; Zuckerman SH Biochem Biophys Res Commun; 2002 Jun; 294(3):660-6. PubMed ID: 12056820 [TBL] [Abstract][Full Text] [Related]
37. Inhibition of histone deacetylases protects septic mice from lung and splenic apoptosis. Takebe M; Oishi H; Taguchi K; Aoki Y; Takashina M; Tomita K; Yokoo H; Takano Y; Yamazaki M; Hattori Y J Surg Res; 2014 Apr; 187(2):559-70. PubMed ID: 24290430 [TBL] [Abstract][Full Text] [Related]
38. Sodium valproate-induced congenital cardiac abnormalities in mice are associated with the inhibition of histone deacetylase. Wu G; Nan C; Rollo JC; Huang X; Tian J J Biomed Sci; 2010 Mar; 17(1):16. PubMed ID: 20219112 [TBL] [Abstract][Full Text] [Related]
39. Resetting the epigenetic histone code in the MRL-lpr/lpr mouse model of lupus by histone deacetylase inhibition. Garcia BA; Busby SA; Shabanowitz J; Hunt DF; Mishra N J Proteome Res; 2005; 4(6):2032-42. PubMed ID: 16335948 [TBL] [Abstract][Full Text] [Related]
40. [Effects of histone deacetylase inhibitor sodium valproate on the physical and behavioral development of 129SV mice]. Burenkova OV; Aleksandrova EA; Zarayskaya IY Patol Fiziol Eksp Ter; 2015; 59(2):40-5. PubMed ID: 26571806 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]